Posted by Michael Wonder on 02 Jun 2022
COVID-19 vaccine weekly safety report (2 June 2022)
2 June 2022 - To 29 May 2022, the TGA has received 573 reports which have been assessed as likely to be myocarditis from about 40.8 million doses of Comirnaty (Pfizer) and 95 reports which have been assessed as likely to be myocarditis from about 4.4 million doses of Spikevax (Moderna).
No new cases of vaccine-related thrombosis with thrombocytopenia syndrome have been reported this year.
